SI-BONE, Inc. Common Stock (SIBN) is a publicly traded Healthcare sector company. As of October 29, 2026, SIBN trades at $22.43 with a market cap of $978.39M and a P/E ratio of -24.12. SIBN moved +2.75% today. Year to date, SIBN is +12.22%; over the trailing twelve months it is +46.85%. Its 52-week range spans $11.48 to $22.95. Analyst consensus is strong buy with an average price target of $24.83. Rallies surfaces SIBN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for SIBN combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $22.43 |
| Market Cap | $978.39M |
| P/E Ratio | -24.12 |
| EPS | $-0.75 |
| Dividend Yield | 0.00% |
| 52-Week High | $22.95 |
| 52-Week Low | $11.48 |
| Volume | 792.86K |
| Avg Volume | 0 |
| Revenue (TTM) | $167.18M |
| Net Income | $-30.91M |
| Gross Margin | 79.03% |
7 analysts cover SIBN: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $24.83.